Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 19 Source: CRO
- €2.5 billion turnover
-
€1.5 billion
profit - 400 employees
-
31st Dec 18 Source: CRO
- €2.3 billion turnover
-
€1.3 billion
profit - 500 employees
- 5 more years available »
Ranking
By Turnover
(€2.5 billion)- 48th in Top Companies
- 9th in Health
- 6th in Pharma
By Employees
(400)- 431st in Top Companies
- 65th in Health
- 40th in Pharma
- 400
- €2.5 billion
Employees
- Shane Doyle Senior vice president
Latest News
- 4:01pm Etsy plans ‘dozens’ of new jobs in Dublin
- 3:56pm Housing completions down ‘but not as bad as feared’
- 3:53pm Moderna reports first-ever quarterly profit with €1.4bn vaccine sales
- 3:53pm John Dunne company liable for €1.4m stamp duty bill on Walford
- 3:38pm Household net worth reaches record high on savings boom